abstract |
The present invention relates to the improved antiviral activity of 6,6-disubstituted-5,6-dihydropyran-2-one obtained by appropriately placing specific polar substituents at the 3 and / or 6 positions. In addition, these substituents that increase cellular activity further increase the desired properties of these agents as antiviral agents while reducing cytotoxicity. |